Kyntra Bio KYNB
NASDAQ KYNB
$5.24 -0.11 (-2.14%)
As of: Oct 21, 2026 · 12:37 PM EDT

Kyntra Bio (KYNB) EBIT Margin (2014 - 2026)

Updated

Kyntra Bio (KYNB) reported EBIT Margin of -1192.27% for Q2 2026, down 298.20 percentage points from -894.07% a year earlier and down 822.60 percentage points from the prior quarter.

Analysis

Kyntra Bio (KYNB) EBIT Margin (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kyntra Bio's EBIT Margin came in at -665.10%, up 448.54 percentage points year-over-year; for FY2025, it came in at -712.66%, down 204.85 percentage points from FY2024.

  • EBIT Margin has a five-year change of -603.83 percentage points (FY2020 to FY2025).
  • By year, EBIT Margin came in at -507.80% in FY2024 (+181.73 pp), -689.53% in FY2023 (-475.63 pp), -213.90% in FY2022 (-91.28 pp) and -122.62% in FY2021 (-13.79 pp).
  • The Q2 2026 figure ranks as the lowest quarterly EBIT Margin since Q3 2024.
  • Year over year, EBIT Margin gained in three of the last seven quarters, with an average year-over-year change of +300.97 percentage points.
  • The high point for year-over-year EBIT Margin in five years was Q3 2025 (a gain of 38271.10 percentage points); the low point was Q3 2024 (a drop of 38615.81 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -369.66% (Q1 2026), -1058.10% (Q4 2025) and -502.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 28.21%
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 37.86%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn 20.57%
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn -133.21%
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 28.37%
10 Kyntra Bio 21.21 Mn -386.73 Mn 1.47 Mn -1,192.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,192.27%
Mar 31, 2026 -369.66%
Dec 31, 2025 -1,058.10%
Sep 30, 2025 -502.88%
Jun 30, 2025 -894.07%
Mar 31, 2025 -544.72%
Dec 31, 2024 -227.53%
Sep 30, 2024 -38,773.98%
Jun 30, 2024 -4,650.10%
Mar 31, 2024 -193.90%
Sep 30, 2023 -158.18%
Jun 30, 2023 -198.67%
Mar 31, 2023 -210.42%
Dec 31, 2022 -192.49%
Sep 30, 2022 -595.21%
Jun 30, 2022 -262.44%
Mar 31, 2022 -103.56%
Dec 31, 2021 -817.51%
Sep 30, 2021 32.68%
Jun 30, 2021 -549.31%
API Access

Kyntra Bio EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEY